Literature DB >> 7790949

Aging effect on neutral amino acid transport at the blood-brain barrier measured with L-[2-18F]-fluorophenylalanine and PET.

H Ito1, J Hatazawa, M Murakami, S Miura, H Iida, P M Bloomfield, I Kanno, H Fukuda, K Uemura.   

Abstract

UNLABELLED: Neutral amino acids (NAAs) are transported from the blood to the brain using the same carrier system in a competitive fashion. The purpose of this study is to establish a method for evaluating neutral amino acid transport at the blood-brain barrier (BBB) in humans and to examine the aging effect of amino acid transport.
METHODS: A dynamic PET study with L-(2-18F)-fluorophenylalanine (18F-Phe) was performed in 14 normal volunteers (age 21-71 yr; mean +/- s.d., age range 48.0 +/- 17.1 yr). By using a two-compartment model analysis and a weighted integration technique, the influx rate constant K1, the efflux rate constant k2 and distribution volume Vd of 18F-Phe were estimated in various brain structures.
RESULTS: The value of K1 was inversely correlated with plasma NAA concentration (r = -0.69, p < 0.01). The cerebellum showed the highest value of K1, while the white matter showed the lowest. There was no significant change in K1 during aging. The value of k2 was significantly increased with age.
CONCLUSION: No decline of K1 during aging indicated that NAA transport from the blood to the brain is a limiting process of age in amino acid incorporation. Fluorine-18-Phe PET imaging is a feasible method to study NAA transport at the BBB in vivo in humans and can be applied to pathological conditions of the brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790949

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine.

Authors:  T Ogawa; S Miura; M Murakami; H Iida; J Hatazawa; A Inugami; I Kanno; N Yasui; T Sasajima; K Uemura
Journal:  Eur J Nucl Med       Date:  1996-08

2.  Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.

Authors:  Toshio Sasajima; Tadashi Miyagawa; Takamitsu Oku; Juri G Gelovani; Ronald Finn; Ronald Blasberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-13       Impact factor: 9.236

3.  Brain regional alpha-[11C]methyl-L-tryptophan trapping, used as an index of 5-HT synthesis, in healthy adults: absence of an age effect.

Authors:  Pedro Rosa-Neto; Chawki Benkelfat; Yojiro Sakai; Marco Leyton; Jose A Morais; Mirko Diksic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-21       Impact factor: 10.057

4.  Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV.

Authors:  Kayako Isohashi; Eku Shimosegawa; Hiroki Kato; Yasukazu Kanai; Sadahiro Naka; Koichi Fujino; Hiroshi Watabe; Jun Hatazawa
Journal:  EJNMMI Res       Date:  2013-04-15       Impact factor: 3.138

5.  Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study.

Authors:  Kayako Isohashi; Eku Shimosegawa; Sadahiro Naka; Yasukazu Kanai; Genki Horitsugi; Ikuko Mochida; Keiko Matsunaga; Tadashi Watabe; Hiroki Kato; Mitsuaki Tatsumi; Jun Hatazawa
Journal:  EJNMMI Res       Date:  2016-10-18       Impact factor: 3.138

6.  Assessment of Amino Acid/Drug Transporters for Renal Transport of [18F]Fluciclovine (anti-[18F]FACBC) in Vitro.

Authors:  Masahiro Ono; Atsumi Baden; Hiroyuki Okudaira; Masato Kobayashi; Keiichi Kawai; Shuntaro Oka; Hirokatsu Yoshimura
Journal:  Int J Mol Sci       Date:  2016-10-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.